Delhi pharmacies ordered to curb misleading medicine-discount advertising
Delhi’s Drugs Control Department has told licensed pharmacies to stop advertising misleading medicine discounts and retain records supporting genuine offers. The advisory flags steep 60%-80% discount claims as possible signs of questionable sourcing while permitting transparent sales below MRP.
What happened
Delhi Drugs Control Department · Delhi’s Drugs Control Department ordered licensed pharmacies to stop misleading medicine-discount advertising and maintain
Key facts
- 20%
- 60%
- 70%
- 80%
- August 17
- June 19
Why this matters
Acquirers and partners should diligence pharmacy targets’ medicine sourcing, promotional claims, and discount-supporting records as regulatory enforcement increases in Delhi.
What to watch
- Delhi Drugs Control Department inspections, show-cause notices, license suspensions, or public naming of pharmacies over discount advertising.
- Guidance defining documentation standards, permissible discount disclosures, or thresholds that trigger scrutiny.
- Expansion of similar advisories by other state drug-control authorities or central drug regulators.
- Evidence that audits extend from advertising into batch traceability, purchase invoices, distributor authorization, counterfeit diversion, or expired-stock controls.
- Major pharmacy chains revising promotion terms, reducing maximum advertised discounts, or highlighting compliant-pricing credentials.
- Consumer complaints or media investigations linking unusually steep discounts to suspect sourcing or product-quality concerns.
- Audit all Delhi promotional creatives, app banners, marketplace listings, WhatsApp campaigns, and in-store signage for unsupported percentage-off claims.
- Create SKU-level evidence files linking advertised discounts to purchase invoices, distributor agreements, MRP, batch details, inventory records, and promotion approval dates.
- Replace blanket discount language with transparent offers that specify eligible products, final price, discount basis, validity period, exclusions, and stock limits.
- Pause exceptionally deep discounts where gross-margin economics cannot be reconciled with documented legitimate sourcing.
- Train store managers and franchisees on record retention, approved advertising language, and escalation procedures for regulator queries.
- Assess exposure of third-party sellers, franchise outlets, and delivery partners whose listings may create retailer-level compliance risk.